Jie Yang
@jieyang437.bsky.social
Group Leader of Cancer Immunology
University of Oxford
University of Oxford
One week left to apply for the postdoc position in my lab at Oxford @ox.ac.uk
Join our exciting cancer immunology research at @oncology.ox.ac.uk, @oxfordcancer.bsky.social & @oxcio.bsky.social.
Deadline: 11 August 2025 (noon).
Join our exciting cancer immunology research at @oncology.ox.ac.uk, @oxfordcancer.bsky.social & @oxcio.bsky.social.
Deadline: 11 August 2025 (noon).
We're recruiting a postdoc to join my lab at @oncology.ox.ac.uk & @oxcio.bsky.social to understand immune regulation in cancer and develop new approaches for cancer prevention and metastasis.
Deadline: 11 August 2025
my.corehr.com/pls/uoxrecru...
Lab info: www.oncology.ox.ac.uk/team/jie-yang
Deadline: 11 August 2025
my.corehr.com/pls/uoxrecru...
Lab info: www.oncology.ox.ac.uk/team/jie-yang
Job Details
my.corehr.com
August 4, 2025 at 10:56 AM
One week left to apply for the postdoc position in my lab at Oxford @ox.ac.uk
Join our exciting cancer immunology research at @oncology.ox.ac.uk, @oxfordcancer.bsky.social & @oxcio.bsky.social.
Deadline: 11 August 2025 (noon).
Join our exciting cancer immunology research at @oncology.ox.ac.uk, @oxfordcancer.bsky.social & @oxcio.bsky.social.
Deadline: 11 August 2025 (noon).
We're recruiting a postdoc to join my lab at @oncology.ox.ac.uk & @oxcio.bsky.social to understand immune regulation in cancer and develop new approaches for cancer prevention and metastasis.
Deadline: 11 August 2025
my.corehr.com/pls/uoxrecru...
Lab info: www.oncology.ox.ac.uk/team/jie-yang
Deadline: 11 August 2025
my.corehr.com/pls/uoxrecru...
Lab info: www.oncology.ox.ac.uk/team/jie-yang
Job Details
my.corehr.com
July 18, 2025 at 10:19 AM
We're recruiting a postdoc to join my lab at @oncology.ox.ac.uk & @oxcio.bsky.social to understand immune regulation in cancer and develop new approaches for cancer prevention and metastasis.
Deadline: 11 August 2025
my.corehr.com/pls/uoxrecru...
Lab info: www.oncology.ox.ac.uk/team/jie-yang
Deadline: 11 August 2025
my.corehr.com/pls/uoxrecru...
Lab info: www.oncology.ox.ac.uk/team/jie-yang
Reposted by Jie Yang
New results from the ALASCCA prospective randomised controlled trial showing daily #aspirin reduces colorectal cancer recurrence by ~50% in patients with PIK3CA or related mutations. Findings extend benefits of aspirin beyond Lynch syndrome cancers to nearly 40% of CRCs ascopubs.org/doi/10.1200/...
Low-dose aspirin to reduce recurrence rate in colorectal cancer patients with PI3K pathway alterations: 3-year results from a randomized placebo-controlled trial.
LBA125Background: Colorectal cancer (CRC) affects 1.9 million individuals globally each year. Among
patients with stage II-III CRC, 20-40% develop metastatic disease. Aspirin lowers
the incidence of a...
ascopubs.org
March 25, 2025 at 12:35 PM
New results from the ALASCCA prospective randomised controlled trial showing daily #aspirin reduces colorectal cancer recurrence by ~50% in patients with PIK3CA or related mutations. Findings extend benefits of aspirin beyond Lynch syndrome cancers to nearly 40% of CRCs ascopubs.org/doi/10.1200/...
Reposted by Jie Yang
Research Highlight of our recent paper by @jieyang437.bsky.social on Aspirin and cancer metastasis in Nature Reviews Immunology. Thanks to Yvonne Bordon for a crystal clear account of the experimental findings www.nature.com/articles/s41...
Aspirin helps T cells to stop cancer spread - Nature Reviews Immunology
Drugs like aspirin can enhance the anti-metastatic activity of T cells by blocking a platelet-mediated pathway of suppression.
www.nature.com
March 25, 2025 at 1:34 PM
Research Highlight of our recent paper by @jieyang437.bsky.social on Aspirin and cancer metastasis in Nature Reviews Immunology. Thanks to Yvonne Bordon for a crystal clear account of the experimental findings www.nature.com/articles/s41...
Reposted by Jie Yang
Congrats to @jieyang437.bsky.social & Rahul for this awesome work on metastasis
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity - Nature
Inhibition of cyclooxygenase 1 releases T cells from immunosuppression by platelet-derived thromboxane A2, thereby enhancing the immune response against metastasis.
www.nature.com
March 6, 2025 at 8:32 AM
Congrats to @jieyang437.bsky.social & Rahul for this awesome work on metastasis
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Reposted by Jie Yang
Brilliant new paper from Jie Yang @jieyang437.bsky.social and Rahul Roychoudhuri @roychoudhurilab.bsky.social linking aspirin to immune-mediated prevention of cancer metastasis.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity - Nature
Inhibition of cyclooxygenase 1 releases T cells from immunosuppression by platelet-derived thromboxane A2, thereby enhancing the immune response against metastasis.
www.nature.com
March 5, 2025 at 4:58 PM
Brilliant new paper from Jie Yang @jieyang437.bsky.social and Rahul Roychoudhuri @roychoudhurilab.bsky.social linking aspirin to immune-mediated prevention of cancer metastasis.
www.nature.com/articles/s41...
www.nature.com/articles/s41...